Beth Ann Martin, MD
Hematology/Oncology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Martin’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G64813 · Current
Licensed to practise in California · since 1999 · expires 2027-06-30 · Mount Sinai School of Medicine of New York University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$56,201
Medicare paid this office $56,201 for 214 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 88 | $20,546 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $10,378 | $155 |
| Long return visit (40+ min) | 19 | $4,745 | $122 |
| Long return visit (40+ min) | 12 | $3,636 | $173 |
| Return visit (30+ min) | 13 | $2,480 | $124 |
See all 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 88 | $20,546 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $10,378 | $155 |
| Long return visit (40+ min) | 19 | $4,745 | $122 |
| Long return visit (40+ min) | 12 | $3,636 | $173 |
| Return visit (30+ min) | 13 | $2,480 | $124 |
| Short return visit (20+ min) | 11 | $1,707 | $85 |
| Return visit (30+ min) | 16 | $1,668 | $88 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 40 | $1,230 | $31 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,060 | $71 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $746 | $44 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 17 | $524 | $15 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 13 | $360 | $15 |
Who their Medicare patients are
214 Original Medicare patients in 2024. Average age 71 · Under 65 19% · 85 and older 8% · Women 53% · Also on Medicaid 32% · Health risk score 2.80. Sicker patients than 9 in 10 peers; the typical hematology-oncology clinician is at 2.04.
Conditions among them: High blood pressure 75% · Chronic kidney disease 43% · Coronary heart disease 42% · Heart failure 39% · Diabetes 33% · Atrial fibrillation 33% · Depression 28% · Stroke 25% · COPD 23% · Cancer 21% · Dementia 20%.
The office billed $243,821, Medicare allowed $71,314 and paid $56,201; for 603 services of 28 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 214 | 603 | 71 | 2.80 | $243,821 | $56,201 |
| 2023 | 216 | 467 | 71 | 2.76 | $196,855 | $46,106 |
| 2022 | 210 | 480 | 72 | 2.81 | $212,844 | $45,918 |
| 2021 | 205 | 444 | 71 | 2.72 | $199,516 | $45,289 |
| 2020 | 218 | 529 | 69 | 2.90 | $198,351 | $50,193 |
| 2019 | 243 | 731 | 71 | 3.13 | $203,201 | $62,624 |
| 2018 | 235 | 548 | 70 | 2.92 | $150,182 | $51,456 |
| 2017 | 257 | 645 | 70 | 2.93 | $201,086 | $57,910 |
| 2016 | 303 | 847 | 71 | 2.54 | $287,109 | $76,010 |
| 2015 | 363 | 1,079 | 71 | 2.35 | $366,862 | $99,362 |
| 2014 | 105 | 301 | 73 | 1.89 | $95,622 | $27,728 |
| 2013 | 15 | 23 | 73 | 2.34 | $8,716 | $2,322 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 72 | $19,128 | $109 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 64 | $10,395 | $160 |
| Long return visit (40+ min) | 17 | $3,792 | $131 |
| Return visit (30+ min) | 16 | $1,897 | $90 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,794 | $120 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,607 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,532 | $73 |
| Short return visit (20+ min) | 21 | $1,525 | $56 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 47 | $1,362 | $29 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $723 | $45 |
2022: 7 services
| Long return visit (40+ min) | 54 | $11,038 | $125 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 56 | $10,843 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $7,570 | $180 |
| Return visit (30+ min) | 53 | $5,740 | $83 |
| Short return visit (20+ min) | 51 | $3,450 | $50 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,719 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,102 | $65 |
2021: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $11,551 | $95 |
| Long return visit (40+ min) | 44 | $10,010 | $132 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $8,784 | $183 |
| Return visit (30+ min) | 34 | $3,894 | $88 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,381 | $125 |
| Short return visit (20+ min) | 29 | $1,994 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,527 | $66 |
| Short return visit | 12 | $590 | $33 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $495 | $35 |
2020: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 58 | $13,696 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $11,459 | $188 |
| Long return visit (40+ min) | 31 | $5,482 | $102 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $5,153 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 38 | $3,194 | $68 |
| Return visit (30+ min) | 31 | $2,229 | $66 |
| Short return visit (20+ min) | 28 | $1,674 | $44 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,412 | $94 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 30 | $1,311 | $34 |
2019: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 81 | $14,998 | $94 |
| Long return visit (40+ min) | 53 | $12,146 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 58 | $11,012 | $184 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,950 | $124 |
| Return visit (30+ min) | 38 | $4,019 | $66 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 61 | $4,019 | $35 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 38 | $3,234 | $66 |
| Short return visit (20+ min) | 36 | $2,113 | $43 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,817 | $91 |
| New patient visit (60+ min) | 11 | $1,675 | $152 |
2018: 10 services
| Long return visit (40+ min) | 67 | $12,348 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $10,205 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $9,278 | $182 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 36 | $4,400 | $122 |
| Return visit (30+ min) | 46 | $4,364 | $67 |
| New patient visit (60+ min) | 17 | $2,559 | $151 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $1,700 | $63 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 37 | $1,609 | $35 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,437 | $90 |
| New patient visit (45+ min) | 11 | $1,038 | $94 |
2017: 11 services
| Long return visit (40+ min) | 84 | $16,686 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 58 | $11,059 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $7,572 | $93 |
| Return visit (30+ min) | 63 | $6,389 | $64 |
| New patient visit (60+ min) | 21 | $3,157 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,332 | $65 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 40 | $2,096 | $35 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,953 | $122 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 16 | $1,435 | $90 |
| New patient visit (45+ min) | 13 | $1,386 | $107 |
| Short return visit (20+ min) | 24 | $1,087 | $40 |
2016: 12 services
| Long return visit (40+ min) | 92 | $18,988 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 91 | $17,962 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 69 | $13,159 | $180 |
| Return visit (30+ min) | 49 | $4,623 | $67 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $3,766 | $121 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 59 | $3,000 | $34 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $2,765 | $64 |
| New patient visit (45+ min) | 21 | $2,307 | $110 |
| New patient visit (60+ min) | 13 | $1,932 | $149 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,695 | $89 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,556 | $97 |
| Short return visit (20+ min) | 24 | $1,094 | $42 |
2015: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 92 | $29,572 | $93 |
| Long return visit (40+ min) | 84 | $16,597 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $14,596 | $180 |
| Return visit (30+ min) | 94 | $9,300 | $62 |
| New patient visit (60+ min) | 52 | $7,567 | $146 |
| Hospital discharge day management, more than 30 minutes | 45 | $6,047 | $98 |
| New patient visit (45+ min) | 40 | $4,155 | $104 |
| Short return visit (20+ min) | 71 | $3,272 | $42 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,322 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,688 | $65 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $802 | $35 |
2014: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $9,948 | $92 |
| Long return visit (40+ min) | 20 | $3,453 | $99 |
| New patient visit (60+ min) | 19 | $2,842 | $150 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,338 | $180 |
| Return visit (30+ min) | 18 | $1,538 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,537 | $64 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,448 | $97 |
| New patient visit (45+ min) | 11 | $1,272 | $116 |
Medicaid work
$3,867 in 2024
Medicaid paid $3,867 for 78 billed services this clinician did in 2024, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 78 | $3,867 |
| 2024 | 78 | 1 | 16 | $3,867 |
| 2023 | 88 | 1 | 16 | $4,923 |
| 2021 | 18 | 1 | 12 | $623 |
| 2020 | 17 | 1 | 13 | $958 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 88 | $4,923 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 18 | $623 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 17 | $958 |
Drugs they prescribed that Part D paid
$203,110
Pharmacies billed $203,110 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 19% of their Part D prescriptions (38 of 203) in 2024. A higher opioid share than 9 in 10 peers; the typical hematology-oncology clinician is at 5%. Long-acting opioids: 32% of their opioid prescriptions.
136 generic and 67 brand-name prescriptions · $203,110 in drug cost · 29 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Zarxio | 11 | $30,891 | $2,808 |
| Tranexamic Acid | 18 | $672 | $37 |
| Hydrocodone-Acetaminophen | 13 | $510 | $39 |
Year by year
| 2024 | 203 | 32 | 19% (38) | 33% | $203,110 |
| 2023 | 95 | 19 | None | None | $177,650 |
| 2022 | 187 | 40 | 6% (12) | None | $493,756 |
| 2021 | 114 | 23 | 11% (12) | None | $149,542 |
| 2020 | 71 | 30 | None | 27% | $76,705 |
| 2019 | 200 | 50 | 6% (12) | 28% | $305,887 |
| 2018 | 225 | 42 | 8% (18) | 38% | $514,232 |
| 2017 | 281 | 60 | 7% (20) | None | $628,272 |
| 2016 | 276 | 51 | 15% (40) | 40% | $570,322 |
| 2015 | 296 | 70 | None | 51% | $1,074,455 |
| 2014 | 36 | 15 | None | 33% | $82,285 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 2 drugs
| Tranexamic Acid | 14 | $559 | $40 |
| Desmopressin Acetate | 12 | $313 | $26 |
2019: 3 drugs
| Revlimid | 12 | $146,649 | $12,221 |
| Prednisone | 20 | $187 | $9 |
| Levothyroxine | 11 | $141 | $13 |
2018: 5 drugs
| Revlimid | 19 | $144,776 | $7,620 |
| Promacta | 12 | $95,366 | $7,947 |
| Eliquis | 11 | $5,434 | $494 |
| Hydroxyurea | 11 | $240 | $22 |
| Prednisone | 15 | $103 | $7 |
2017: 5 drugs
| Revlimid | 27 | $193,137 | $7,153 |
| Eliquis | 19 | $8,821 | $464 |
| Hydroxyurea | 27 | $523 | $19 |
| Prednisone | 18 | $193 | $11 |
| Acyclovir | 11 | $111 | $10 |
2016: 6 drugs
| Revlimid | 36 | $215,039 | $5,973 |
| Imbruvica | 14 | $141,712 | $10,122 |
| Hydroxyurea | 20 | $396 | $20 |
| Prednisone | 20 | $337 | $17 |
| Ondansetron | 11 | $280 | $25 |
| Dexamethasone | 13 | $235 | $18 |
2015: 5 drugs
| Jakafi | 67 | $680,310 | $10,154 |
| Revlimid | 22 | $148,269 | $6,739 |
| Gleevec | 13 | $146,004 | $11,231 |
| Hydroxyurea | 33 | $903 | $27 |
| Prednisone | 12 | $223 | $19 |
Money from drug and device companies
$5,448 in 2020
| 2020 | 1 | 1 | $5,448 | $5,448 |
| 2019 | 1 | 4 | $10,725 | $19,480 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genentech | Non-Covered Product | $5,448 | 1 payment
|
See the published payment
| Genentech | Consulting · 2020-03-11 | Non-Covered Product | $5,448 |
See earlier years (2019)
2019: $19,480
| F. Hoffmann-La Roche AG | Non-Covered Product | $19,480 | 4 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1134154420
- Licence
- CA G64813California G64813: Current · expires 2027-06-30
- Trained
- Icahn School of Medicine at Mount Sinai, 1987
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RH0000X (207RH0000X); Internal medicine (207R00000X); Federal specialty code 207RH0003X (207RH0003X); Medical oncology (207RX0202X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-07-12
- NPI last updated
- 2024-04-15
- NPI record certified
- 2024-04-15
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3801 Miranda Ave, Palo Alto, CA, 94304